Prostate cancer: ESMO Consensus Conference Guidelines 2012.

Details

Serval ID
serval:BIB_3E5CFB01FA34
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Title
Prostate cancer: ESMO Consensus Conference Guidelines 2012.
Journal
Annals of oncology
Author(s)
Horwich A., Hugosson J., de Reijke T., Wiegel T., Fizazi K., Kataja V.
Working group(s)
Panel Members, European Society for Medical Oncology
Contributor(s)
Parker C., Bellmunt J., Berthold D., Bill-Axelson A., Carlsson S., Daugaard G., De Meerleer G., de Reijke T., Dearnaley D., Fizazi K., Fonteyne V., Gillessen S., Heinrich D., Horwich A., Hugosson J., Kataja V., Kwiatkowski M., Nilsson S., Padhani A., Papandreou C., Parker C., Roobol M., Sella A., Valdagni R., Van der Kwast T., Verhagen P., Wiegel T.
ISSN
1569-8041 (Electronic)
ISSN-L
0923-7534
Publication state
Published
Issued date
05/2013
Peer-reviewed
Oui
Volume
24
Number
5
Pages
1141-1162
Language
english
Notes
Publication types: Consensus Development Conference ; Journal Article ; Practice Guideline ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Abstract
The first ESMO Consensus Conference on prostate cancer was held in Zurich, Switzerland, on 17-19 November 2011, with the participation of a multidisciplinary panel of leading professionals including experts in methodological aspects. Before the conference, the expert panel prepared clinically relevant questions about prostate cancer in four areas for discussion as follows: diagnosis and staging, management of early localized disease, management of advanced localized disease and systemic disease. All relevant scientific literature, as identified by the experts, was reviewed in advance. During the Consensus Conference, the panel developed recommendations for each specific question. The recommendations detailed here are based on an expert consensus after careful review of published data. All participants have approved this final update.

Keywords
Antineoplastic Agents, Hormonal/therapeutic use, Digital Rectal Examination, Humans, Lymph Nodes, Male, Prostate-Specific Antigen/analysis, Prostatic Neoplasms/diagnosis, Prostatic Neoplasms/drug therapy, Prostatic Neoplasms/radiotherapy, Prostatic Neoplasms/surgery
Pubmed
Open Access
Yes
Create date
30/11/2016 22:28
Last modification date
20/08/2019 13:35
Usage data